Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $2.94 billion
- Book Value:
- Revenue TTM:
- $1.05 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $575.75 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
CONMED Corporation had its IPO on 1987-07-23 under the ticker symbol CNMD.
The company operates in the Healthcare sector and Medical Devices industry. CONMED Corporation has a staff strength of 4,100 employees.
Shares of CONMED Corporation opened at $96.02 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $94.04 - $97.11, and closed at $97.
This is a +0.64% increase from the previous day's closing price.
A total volume of 335,314 shares were traded at the close of the day’s session.
In the last one week, shares of CONMED Corporation have increased by +5.84%.
CONMED Corporation's Key Ratios
CONMED Corporation has a market cap of $2.94 billion, indicating a price to book ratio of 3.877 and a price to sales ratio of 2.4615.
In the last 12-months CONMED Corporation’s revenue was $1.05 billion with a gross profit of $575.75 million and an EBITDA of $156.75 million. The EBITDA ratio measures CONMED Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, CONMED Corporation’s operating margin was 8.54% while its return on assets stood at 2.75% with a return of equity of -10.53%.
In Q4, CONMED Corporation’s quarterly earnings growth was a positive 16.4% while revenue growth was a negative 8.4%.
CONMED Corporation’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-2.78 per share while it has a forward price to earnings multiple of 27.027 and a PEG multiple of 5.29. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CONMED Corporation’s profitability.
CONMED Corporation stock is trading at a EV to sales ratio of 3.538 and a EV to EBITDA ratio of 57.6193. Its price to sales ratio in the trailing 12-months stood at 2.4615.
CONMED Corporation stock pays annual dividends of $0.8 per share, indicating a yield of 0.89% and a payout ratio of 30.19%.
Balance sheet and cash flow metrics
- Total Assets
- $2.30 billion
- Total Liabilities
- $296.55 million
- Operating Cash Flow
- Capital Expenditure
- $5.68 million
- Dividend Payout Ratio
CONMED Corporation ended 2023 with $2.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.30 billion while shareholder equity stood at $745.55 million.
CONMED Corporation ended 2023 with $66.73 million in deferred long-term liabilities, $296.55 million in other current liabilities, 313000.00 in common stock, $412.63 million in retained earnings and $815.43 million in goodwill. Its cash balance stood at $28.94 million and cash and short-term investments were $28.94 million. The company’s total short-term debt was $69,746,000 while long-term debt stood at $985.08 million.
CONMED Corporation’s total current assets stands at $581.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $191.35 million compared to accounts payable of $73.39 million and inventory worth $332.32 million.
In 2023, CONMED Corporation's operating cash flow was $-6318000.00 while its capital expenditure stood at $5.68 million.
Comparatively, CONMED Corporation paid $0.30 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
CONMED Corporation stock is currently trading at $97 per share. It touched a 52-week high of $154.1842 and a 52-week low of $154.1842. Analysts tracking the stock have a 12-month average target price of $112.17.
Its 50-day moving average was $96.48 and 200-day moving average was $91.03 The short ratio stood at 9.17 indicating a short percent outstanding of 0%.
Around 408.7% of the company’s stock are held by insiders while 11976.4% are held by institutions.
Frequently Asked Questions About CONMED Corporation
Similar Industry Stocks (Medical Devices)
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.